Table 3.
Effect of ERFE pre-treatment on hepatic liver peroxidation and antioxidant profile in rats challenged with diclofenac.
| Group | MDA nmol/g Tissue | GSH nmol/g Tissue | GPx nmol/min/mg Protein | GR nmol/min/mg Protein | GST nmol/min/mg Protein |
|---|---|---|---|---|---|
| Control | 0.385 ± 0.021 | 6.34 ± 0.38 | 0.132 ± 0.008 | 0.220 ± 0.017 | 0.291 ± 0.014 |
| ERFE | 0.369 ± 0.018 * | 7.30 ± 0.36 * | 0.152 ± 0.006 * | 0.258 ± 0.015 * | 0.325 ± 0.017 * |
| Diclofenac | 0.486 ± 0.024 * | 4.96 ± 0.19 * | 0.119 ± 0.005 * | 0.173 ± 0.016 * | 0.242 ± 0.026 * |
| ERFE + DF | 0.399 ± 0.026 + | 6.12 ± 0.25 *+ | 0.138 ± 0.005 + | 0.220 ± 0.015 + | 0.294 ± 0.023 + |
* p < 0.05 vs. control group; + p < 0.05 vs. DF-treated group.